These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22842882)

  • 21. [Developments in blood transfusion].
    Krusius T; Porkka K
    Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306
    [No Abstract]   [Full Text] [Related]  

  • 22. [Safety of blood and blood products in the face of recent reports on the transmissibility of Alzheimer's disease in an animal experiment. Explanation to comment].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Apr; 56(4):585-9. PubMed ID: 23529605
    [No Abstract]   [Full Text] [Related]  

  • 23. [Time to introduce audit of transfusion treatment. Local transfusion committees should be established in Sweden].
    Schött U; Norda R; Ostlund I; Wikman A
    Lakartidningen; 2010 Dec 15-21; 107(50):3216-20. PubMed ID: 21294336
    [No Abstract]   [Full Text] [Related]  

  • 24. Viral safety of human plasma-derived medicinal products: impact of regulation requirements.
    Velthove KJ; Over J; Abbink K; Janssen MP
    Transfus Med Rev; 2013 Jul; 27(3):179-83. PubMed ID: 23886505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of microbial safety.
    Barbara JA
    Hematol J; 2004; 5 Suppl 3():S69-73. PubMed ID: 15190282
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evolution of neonatal transfusion practices: current recommendations].
    Plaisant F
    Transfus Clin Biol; 2011 Apr; 18(2):262-8. PubMed ID: 21440478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recommendations for rationally-based hemotherapy].
    Welte M; Hachenberg T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Mar; 44(3):184-5. PubMed ID: 19266419
    [No Abstract]   [Full Text] [Related]  

  • 28. 7th International Association of Biological Standardization (IABS) Symposium on Advances in Transfusion Safety.
    Teo D
    Biologicals; 2012 May; 40(3):169. PubMed ID: 22507451
    [No Abstract]   [Full Text] [Related]  

  • 29. [Virologic safety of donor blood after NAT testing].
    Harritshøj LH; Erikstrup C; Ullum H
    Ugeskr Laeger; 2012 Mar; 174(12):796. PubMed ID: 22433553
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review.
    Pruett CR; Vermeulen M; Zacharias P; Ingram C; Tayou Tagny C; Bloch EM
    Transfus Med Rev; 2015 Jan; 29(1):35-44. PubMed ID: 25447555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efforts Toward Elimination of Infectious Agents in Blood Products.
    Jacquot C; Delaney M
    J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Transfusions of blood and blood products and virus infections].
    Wróblewska M; Piotrowska E; ĺuczak M
    Postepy Hig Med Dosw; 2002; 56(2):221-40. PubMed ID: 12107964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Costs of safety of blood and blood products].
    Seifried E; Soedel G
    Zentralbl Chir; 1995; 120(8):584-92. PubMed ID: 7571889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AABB contributions to plasma safety.
    Triulzi DJ
    Transfusion; 2012 May; 52 Suppl 1():5S-8S. PubMed ID: 22578373
    [No Abstract]   [Full Text] [Related]  

  • 36. [Techniques of preparation and indications of labile blood products].
    Clément S
    Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood donation].
    Giraud Ch; Korach JM; Andreu G; Lacaze C; Vaicle M; Schooneman F; Guillevin L
    Transfus Clin Biol; 2002 Jul; 9(3):168-78. PubMed ID: 12357702
    [No Abstract]   [Full Text] [Related]  

  • 38. Public policy, blood safety and haemovigilance.
    Roberts DJ
    Transfus Med; 2011 Dec; 21(6):357-8. PubMed ID: 22082175
    [No Abstract]   [Full Text] [Related]  

  • 39. Multilayer-strategy to enhance optimal safety of the blood supply: The role of pathogen inactivation for optimizing recipient safety and helping health care cost containment: Moderator views.
    Seghatchian J
    Transfus Apher Sci; 2015 Apr; 52(2):233-6. PubMed ID: 25748230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Respiratory and infectious complications of blood transfusion].
    Wautier MP; Wautier JL
    Rev Prat; 2012 May; 62(5):699-700. PubMed ID: 22730808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.